Everything CBD: A Training for Community Pharmacists
Sponsored by: Sycamore BioPharma
- Training Description
Today’s pharmacists face both a clinical and ethical dilemma surrounding the medical use of a DEA Schedule 1 drug, marijuana; specifically, one of its components: cannabidiol (CBD). Evidence-based drug information on over the counter (OTC) and prescription medications with product safety guidelines have been the cornerstones of pharmacy practice. With the use of medical cannabis becoming commonplace in many states, pharmacists are often asked to give patients drug information on cannabis-derived products. This training is intended to provide pharmacists with the tools and resources necessary to ensure safe and effective use of CBD products.
Naloxone911: SCPhA’s Training for Community Pharmacists
- Training Description
Opioids are the most common cause of fatal drug-induced respiratory depression and the time for epidemic-ending intervention is now. Naloxone is a safe and effective preventative strategy to prevent drug-induced respiratory depression. Communities who provide access to naloxone have shown significant reductions in emergency department visits for opioid-related breathing emergencies. Pharmacists play a vital role in harm reduction through proper medication management, opioid-induced respiratory depression risk reduction education, and provision of naloxone rescue kits to the community. Register for this training to learn about the available formulations of naloxone products and the logistics of dispensing them.
Coming Soon
Comprehending Contraception: SCPhA’s Training on Hormonal Contraceptives
- Training Description
In the US, hormonal contraceptives are approved for use as prescription products. To increase access to these products, many states allow pharmacists to dispense certain hormonal contraceptives (typically oral and patch forms) under collaborative practice agreements (CPAs), and some states have established state-wide protocols that allow pharmacists to furnish hormonal contraceptives to patients. This training is intended to provide pharmacists with an overview of commercially available hormonal contraceptives, update on legislation allowing pharmacists to prescribe birth control, and effective strategies for communicating and managing contraceptive therapy.